LONG FACTOR CERTIFICATE - PFIZER INC Stock

Certificat

Y2HQH

DE000GQ8Z3D8

Real-time Euronext Paris 09:59:53 2024-06-14 EDT
0.3 EUR +3.45% Intraday chart for LONG FACTOR CERTIFICATE - PFIZER INC
Current month-52.46%
1 month-65.06%
Date Price Change
24-06-14 0.3 +3.45%
24-06-13 0.29 -9.38%
24-06-12 0.32 -13.51%
24-06-11 0.37 +2.78%
24-06-10 0.36 -41.94%

Real-time Euronext Paris

Last update June 14, 2024 at 09:59 am

More quotes

Static data

Product typeExotic Products
Buy / SellCALL
Underlying PFIZER, INC.
Issuer Goldman Sachs
Y2HQH
ISINDE000GQ8Z3D8
Date issued 2023-11-14
Strike 25.52 $
Maturity Unlimited
Parity 6.7 : 1
Emission price 21.85
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 37.63
Lowest since issue 0.24
Spread 0.01
Spread %3.13%

Company Profile

Pfizer, Inc. is the world's leading pharmaceutical group. Net sales break down by family of products as follows: - primary care products (72.8%): medicines used in internal medicine, vaccines, medicines for the prevention and treatment of Covid-19, antivirals, mRNA-based products, etc.; - specialty care products (13.8%): medicines used in immunology, in hospitals and for the treatment of rare diseases, anti-inflammatory medicines, etc.; - oncology products (12.1%); - other (1.3%). At the end of 2022, the group had more than 35 manufacturing sites worldwide. Net sales are distributed geographically as follows: the United States (42.3%), Europe (21.9%) and other (35.8%).
Sector
-
More about the company

Ratings for Pfizer, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Pfizer, Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
25
Last Close Price
27.65 USD
Average target price
31.92 USD
Spread / Average Target
+15.43%
Consensus
  1. Stock Market
  2. Certificates
  3. Y2HQH Certificat